Reply to the Editor  by Daubeney, Piers & Webber, Steven
a research program with the aim of con-
structing recellularized homografts so that
we can offer new alternatives to mechani-
cal prostheses, as other institutes are doing.
The role of the patient is a determining
factor in the choice of the prosthesis today.
Patients are well informed and their choice
is opening a new era in the field of biologic
prostheses.
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Is there any difference between
surgical outflow reconstruction and
transcatheter valvotomy in patients
with pulmonary atresia with intact
ventricular septum?
To the Editor:
I read with great interest the article by
Daubeney and associates1 for the UK and
Ireland Collaborative Study of Pulmonary
Atresia with Intact Ventricular Septum.
This is an ongoing population study com-
prising 183 patients. The authors report
that independent risk factors for death were
low birth weight, unipartite right ventricu-
lar morphology, and the presence of a di-
lated ventricle.
The primary procedure comprised a
systemic-pulmonary shunt in 81 patients,
percutaneous transcatheter valvotomy in
40 patients, surgical outflow reconstruction
alone in 27 patients, and surgical outflow
reconstruction with a concomitant shunt in
another 18 patients.
I would like to ask some questions about
patients who received surgical outflow recon-
struction and the group of subjects who un-
derwent a percutaneous approach:
1. Was there any difference in terms of
survival between the two groups?
2. How many subjects treated with
a percutaneous approach needed a
systemic-pulmonary shunt after the
transcatheter procedure?
3. Was there any difference between
the two groups in terms of right
ventricular morphology and/or tri-
cuspid valvular z score?
4. Was there any difference in terms of
the achievement of type of repair
(biventricular, univentricular, mixed,
or one-and-a-half ventricular)?
In fact, there is no agreement about the
best approach to use to open the right ven-
tricular outflow tract in subjects who have
the membranous type of pulmonary atresia
with intact ventricular septum with a tripar-
tite or bipartite right ventricle. Finally, no
comparative studies exist.
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Reply to the Editor:
In the UK and Ireland Collaborative
Study of Pulmonary Atresia with Intact
Ventricular Septum, 67 of 183 patients
underwent a primary procedure on the
outflow tract without construction of a
shunt: surgical in 27 and transcatheter in
40. Mortality was 26% in the surgical
group and 20% in the catheter group.
Among the survivors, risk of reinterven-
tion within 6 weeks to increase flow of
blood to the lungs was significantly
higher in those who underwent catheter
intervention than in those who underwent
surgery. In many cases this was due to
failure to cross the atretic pulmonary
valve during the initial catheter proce-
dure. When the pulmonary valve was
successfully crossed at catheterization, the
proportion requiring early reintervention was
comparable with that of those treated sur-
gically.
These data represent the earliest expe-
riences in the United Kingdom and Ireland
of catheter perforation and dilatation of the
atretic pulmonary valve in this condition.
In cases in which the atretic pulmonary
valve can successfully be crossed, trans-
catheter intervention can produce good out-
comes in the short term comparable with
those achieved by surgery. Full details will
be published shortly.
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